Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion type Assertion NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_head.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion description "[PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of response to mitogen-activated protein/extracellular signal-regulated kinase inhibitors and anti-EGF receptor antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_provenance.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion evidence source_evidence_literature NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_provenance.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion SIO_000772 23633456 NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_provenance.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion wasDerivedFrom befree-2016 NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_provenance.
- NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_assertion wasGeneratedBy ECO_0000203 NP1073820.RA3WP1P3jnDLX2uJp-hP99sx_SNv9pKL5_OLjmTBgKJN8130_provenance.